Ganot Capital

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
2
in our dataset
Rounds participated
2
Rounds led
0
Rounds' value
$35.0M
total disclosed, rounds participated
Stages
—

Portfolio · 2

Notal Vision
Remote Patient Monitoring for Retinal Diseases
1 round $25.0M committed Latest: 2019-12
Kyma Medical Technologies
Remote Monitoring for Patients with Chronic Cardiac Diseases
1 round $10.0M committed Latest: 2013-10

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences3

Q&A

What is Ganot Capital's primary sector focus?
Ganot Capital primarily focuses on the Health Tech & Life Sciences sector, with all three of its listed portfolio companies and its single exit falling within this area.
Can you name some of Ganot Capital's notable portfolio companies?
Ganot Capital's portfolio includes Azura Ophthalmics, which develops ophthalmic keratolytics.
Has Ganot Capital had any exits?
Yes, Ganot Capital had an exit in September 2015 with the acquisition of Kyma Medical Technologies by Zoll for $35 million. Kyma Medical Technologies specialized in remote monitoring for patients with chronic cardiac diseases.
What is the most recent investment activity by Ganot Capital?
Ganot Capital's most recent recorded investment activity was in October 2020.
What is the total amount raised by Notal Vision, a Ganot Capital portfolio company?
Notal Vision, a portfolio company of Ganot Capital, has raised $94.05 million.
What is the total amount raised by Azura Ophthalmics, a Ganot Capital portfolio company?
Azura Ophthalmics, a portfolio company of Ganot Capital, has raised $37.2 million.